NEW YORK (Reuters Health) – A consensus statement compiled by an international panel proposes that the level of platelet reactivity during antiplatelet therapy is a better measure of…
NEW YORK (Reuters Health) – In high vascular risk patients, addition of clopidogrel to treatment with acetylsalicylic acid does not help minimize untoward events, researchers report in the…
NEW YORK (Reuters Health) – The mineral composition of kidney stones reported by commercial laboratories is often inaccurate, investigators at Indiana University, Indianapolis report in the Journal of…
NEW YORK (Reuters Health) – As is seen in certain other gastrointestinal illnesses, the prevalence of low-trauma fractures is higher among patients with chronic pancreatitis than in the…
NEW YORK (Reuters Health) – Elderly subjects who need to void two or more times during the night have an increased risk of sustaining a fracture and of…
NEW YORK (Reuters Health) – Despite numerous advances in treatment, evidence-based outpatient therapy for congestive heart failure (CHF) has not improved since 2002, researchers report in the August…
NEW YORK (Reuters Health) – The 10-year outcomes data from the MASS II trial comparing coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI) and medical treatment for…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy for a year improves cardiac size and performance in patients with mildly symptomatic heart failure, resulting in improved outcomes, according…
NEW YORK (Reuters Health) – Patients with an acute coronary syndrome referred for invasive treatment have similar outcomes whether they are given double-dose or standard-dose clopidogrel plus higher-dose…
NEW YORK (Reuters Health) – By lowering heart rate, the selective sinoatrial current inhibitor ivabradine improves outcomes in patients with chronic heart failure and an elevated heart rate,…